Angiotensin Converting Enzyme 2 News and Research

RSS
miRNAs associated with varying clinical presentations of SARS-CoV-2

miRNAs associated with varying clinical presentations of SARS-CoV-2

Results indicate that Omicron infection induces low levels of neutralizing antibodies in immunocompetent individuals

Results indicate that Omicron infection induces low levels of neutralizing antibodies in immunocompetent individuals

Free SARS-CoV-2 spike protein fragments may trigger platelet activation and clot formation in COVID-19

Free SARS-CoV-2 spike protein fragments may trigger platelet activation and clot formation in COVID-19

SARS-CoV-2 Omicron BA.2.12.1, BA.4 and BA.5 subvariants are superior to their predecessors

SARS-CoV-2 Omicron BA.2.12.1, BA.4 and BA.5 subvariants are superior to their predecessors

SARS-CoV-2 BA.2 poses greater risk to global health than BA.1

SARS-CoV-2 BA.2 poses greater risk to global health than BA.1

Pets living in households with COVID-19 are high likely to seroconvert and become ill

Pets living in households with COVID-19 are high likely to seroconvert and become ill

SARS-CoV-2 inhibition mediated by cellular nucleic acid-binding protein

SARS-CoV-2 inhibition mediated by cellular nucleic acid-binding protein

Study explores SARS-CoV-2 RNA genome's functional interactions with host cell

Study explores SARS-CoV-2 RNA genome's functional interactions with host cell

Multi-omics identify COVID-19 severity predictors and prothrombotic signatures in patients with end-stage kidney disease

Multi-omics identify COVID-19 severity predictors and prothrombotic signatures in patients with end-stage kidney disease

Precision cut slice lung model to study early host viral pathogenesis of SARS-CoV-2 infection

Precision cut slice lung model to study early host viral pathogenesis of SARS-CoV-2 infection

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Study reveals Omicron sub-lineages BA.4 and BA.5 escape neutralizing antibodies elicited in response to BA.1 infection

Study reveals Omicron sub-lineages BA.4 and BA.5 escape neutralizing antibodies elicited in response to BA.1 infection

Features of SARS-CoV-2 Omicron BA.2 sublineage spike protein

Features of SARS-CoV-2 Omicron BA.2 sublineage spike protein

Long COVID is characterized SARS-CoV-2 antigen persistence in the gut mucosa

Long COVID is characterized SARS-CoV-2 antigen persistence in the gut mucosa

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

Study reports an orally available SARS-CoV-2 Mpro inhibitor with potent in vivo antiviral activity

Study reports an orally available SARS-CoV-2 Mpro inhibitor with potent in vivo antiviral activity

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

Study finds curcumin is a potential therapeutic agent against the Omicron variant of SARS-CoV-2

Study finds curcumin is a potential therapeutic agent against the Omicron variant of SARS-CoV-2

Identification of a SARS-CoV-2 neutralizing human monoclonal antibody with a remarkable broad-spectrum neutralization and protection efficacy

Identification of a SARS-CoV-2 neutralizing human monoclonal antibody with a remarkable broad-spectrum neutralization and protection efficacy

Evidence of accelerated epigenetic age in SARS-CoV-2-positive patients

Evidence of accelerated epigenetic age in SARS-CoV-2-positive patients